Increased expression of RUNX1 has been positively correlated with steatosis, fibrosis, and the degree of hepatic inflammation as well as NASH activity score in NAFLD patients [125,127]. This evidence concerns the gene RUNX1 and metabolic dysfunction-associated steatohepatitis.